Global Animal Biotechnology Market 2022-2026

The publisher has been monitoring the animal biotechnology market and it is poised to grow by $3.26 bn during 2022-2026, progressing at a CAGR of 2.82% during the forecast period. The report on the animal biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing growth strategies of market players and growing focus toward animal cloning.

The animal biotechnology market analysis includes the product segment and geographic landscape.

The animal biotechnology market is segmented as below:

By Product

Drug
Vaccine
Diagnostic test
Others

By Geography

North America
Europe
APAC
South America
MEA

This study identifies the use of transgenic animals to produce recombinant proteins as one of the prime reasons driving the animal biotechnology market growth during the next few years.

The report on animal biotechnology market covers the following areas:

Animal biotechnology market sizing
Animal biotechnology market forecast
Animal biotechnology market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading animal biotechnology market vendors that include Bayer AG, Boehringer Ingelheim International GmbH, Heska Corp., Id Vet India Pvt. Ltd., IDEXX Laboratories Inc., Merck and Co. Inc., Pfizer Inc., Santa Cruz Biotechnology Inc., Virbac Group, and Zoetis Inc. Also, the animal biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary

Market Overview

Market Landscape

Market ecosystem
Value chain analysis

Market Sizing

Market definition
Market segment analysis
Market size 2021
Market outlook: Forecast for 2021 - 2026

Five Forces Analysis

Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product

Market segments
Comparison by Product
Drug - Market size and forecast 2021-2026
Vaccine - Market size and forecast 2021-2026
Diagnostic test - Market size and forecast 2021-2026
Others - Market size and forecast 2021-2026
Market opportunity by Product

Customer landscape

Overview

Geographic Landscape

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2021-2026
Europe - Market size and forecast 2021-2026
APAC - Market size and forecast 2021-2026
South America - Market size and forecast 2021-2026
MEA - Market size and forecast 2021-2026
Key leading countries
Market opportunity by geography

Drivers, Challenges, and Trends

Market drivers
Market challenges
Market trends

Vendor Landscape

Overview
Landscape disruption
Competitive landscape

Vendor Analysis

Vendors covered
Market positioning of vendors
Bayer AG
Boehringer Ingelheim International GmbH
Heska Corp.
Id Vet India Pvt. Ltd.
IDEXX Laboratories Inc.
Merck and Co. Inc.
Pfizer Inc.
Santa Cruz Biotechnology Inc.
Virbac Group
Zoetis Inc.
Zoetis Inc. - Segment focus

Appendix

Scope of the report
Currency conversion rates for US$
Research Methodology
List of abbreviations

List of Exhibits

Key Finding 1
Key Finding 2
Key Finding 3
Key Finding 5
Key Finding 6
Key Finding 7
Key Finding 8
Parent market
Market characteristics
Offerings of vendors included in the market definition
Market segments
Global - Market size and forecast 2021 - 2026 ($ million)
Global market: Year-over-year growth 2021 - 2026 (%)
Five forces analysis 2021 & 2026
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition - Five forces 2021
Product - Market share 2021-2026 (%)
Comparison by Product
Drug - Market size and forecast 2021-2026 ($ million)
Drug - Year-over-year growth 2021-2026 (%)
Vaccine - Market size and forecast 2021-2026 ($ million)
Vaccine - Year-over-year growth 2021-2026 (%)
Diagnostic test - Market size and forecast 2021-2026 ($ million)
Diagnostic test - Year-over-year growth 2021-2026 (%)
Others - Market size and forecast 2021-2026 ($ million)
Others - Year-over-year growth 2021-2026 (%)
Market opportunity by Product
Customer landscape
Market share by geography 2021-2026 (%)
Geographic comparison
North America - Market size and forecast 2021-2026 ($ million)
North America - Year-over-year growth 2021-2026 (%)
Europe - Market size and forecast 2021-2026 ($ million)
Europe - Year-over-year growth 2021-2026 (%)
APAC - Market size and forecast 2021-2026 ($ million)
APAC - Year-over-year growth 2021-2026 (%)
South America - Market size and forecast 2021-2026 ($ million)
South America - Year-over-year growth 2021-2026 (%)
MEA - Market size and forecast 2021-2026 ($ million)
MEA - Year-over-year growth 2021-2026 (%)
Key leading countries
Market opportunity by geography ($ million)
Impact of drivers and challenges
Vendor landscape
Landscape disruption
Industry risks
Vendors covered
Market positioning of vendors
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key offerings
Bayer AG - Key customers
Bayer AG - Segment focus
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Business segments
Boehringer Ingelheim International GmbH - Key offerings
Boehringer Ingelheim International GmbH - Key customers
Boehringer Ingelheim International GmbH - Segment focus
Heska Corp. - Overview
Heska Corp. - Business segments
Heska Corp. - Key offerings
Heska Corp. - Key customers
Heska Corp. - Segment focus
Id Vet India Pvt. Ltd. - Overview
Id Vet India Pvt. Ltd. - Product and service
Id Vet India Pvt. Ltd. - Key offerings
Id Vet India Pvt. Ltd. - Key customers
Id Vet India Pvt. Ltd. - Segment focus
IDEXX Laboratories Inc. - Overview
IDEXX Laboratories Inc. - Business segments
IDEXX Laboratories Inc. - Key offerings
IDEXX Laboratories Inc. - Key customers
IDEXX Laboratories Inc. - Segment focus
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Key customers
Merck and Co. Inc. - Segment focus
Pfizer Inc. - Overview
Pfizer Inc. - Business segments
Pfizer Inc. - Key offerings
Pfizer Inc. - Key customers
Pfizer Inc. - Segment focus
Santa Cruz Biotechnology Inc. - Overview
Santa Cruz Biotechnology Inc. - Product and service
Santa Cruz Biotechnology Inc. - Key offerings
Santa Cruz Biotechnology Inc. - Key customers
Santa Cruz Biotechnology Inc. - Segment focus
Virbac Group - Overview
Virbac Group - Business segments
Virbac Group - Key offerings
Virbac Group - Key customers
Virbac Group - Segment focus
Zoetis Inc. - Overview
Zoetis Inc. - Business segments
Zoetis Inc. - Key offerings
Zoetis Inc. - Key customers
Zoetis Inc. - Segment focus
Currency conversion rates for US$
Research Methodology
Validation techniques employed for market sizing
Information sources
List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global animal biotechnology market: Bayer AG, Boehringer Ingelheim International GmbH, Heska Corp., Id Vet India Pvt. Ltd., IDEXX Laboratories Inc., Merck and Co. Inc., Pfizer Inc., Santa Cruz Biotechnology Inc., Virbac Group, and Zoetis Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is use of transgenic animals to produce recombinant proteins.'

According to the report, one of the major drivers for this market is the increasing growth strategies of market players.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.